STAT+: Republicans are using the FTC’s Lina Khan as an excuse for opposing drug pricing bills
WASHINGTON — Congress’ efforts to get more information on the business practices of pharmacy benefit managers are running into an unlikely roadblock: Republicans’ dislike of Federal Trade Commission Chair Lina Khan and her approach to antitrust enforcement.
The Senate Commerce Committee held a hearing Thursday on a bipartisan bill that aims to get the drug middlemen to tell the FTC how much money they make through pharmacy fees and “spread pricing,” a practice of charging insurers more for drugs than the PBMs pay pharmacies, and pocketing the difference.
Continue to STAT+ to read the full story…
Federal Trade Commission Chair Lina Khan
Information Courtesy By: John Wilkerson, #HealthcareNews #Healthcare | Feeds
WASHINGTON — Congress’ efforts to get more information on the business practices of pharmacy benefit managers are running into an unlikely roadblock: Republicans’ dislike of Federal Trade Commission Chair Lina Khan and her approach to antitrust enforcement.
The Senate Commerce Committee held a hearing Thursday on a bipartisan bill that aims to get the drug middlemen to tell the FTC how much money they make through pharmacy fees and “spread pricing,” a practice of charging insurers more for drugs than the PBMs pay pharmacies, and pocketing the difference.
Continue to STAT+ to read the full story…
Federal Trade Commission Chair Lina Khan
Click For More Details
2023-02-17 01:50
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.